The results of our study showed that expression of CXCR4/CXCL12-related genes was significantly downregulated in Npm1wt/c+ mouse BM precursor cells and in human AML samples displaying the NPM1 mutation. This evidence concerns the gene CXCL12 and acute myeloid leukemia.